<DOC>
	<DOCNO>NCT02280057</DOCNO>
	<brief_summary>The investigator want elucidate effect metformin Polycystic Ovary Syndrome ( PCOS ) perform randomize , double-blinded , placebo-controlled cross-over study .</brief_summary>
	<brief_title>Trial With Metformin Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Eligible woman give write informed consent assign 6 month treatment either 850 mg metformin placebo twice daily , follow wash-out period 3 month cross-over alternate treatment another 6 month . Randomization define treatment sequence do inclusion random number table . The appearance tablet identical , patient investigator blind treatment allocation . The randomization code store close envelope participant finish treatment . Participants see one investigator inclusion every second month treatment period , always morning overnight fast least 8 h. They weigh wear light clothing . Waist circumference measure umbilical level hip circumference trochanter region . Systolic diastolic blood pressure measure semiautomatic blood pressure monitor blood sample drawn immediate analysis without respect bleeding period . All participant register bleed period calendar study period 3 month wash-out period . Calculation sample size base assumption least 50 % woman would experience least 30 % menstrual period metformin placebo . Based power 90 ( b = 0.10 ) detect significant difference [ two-sided P-value 0.05 ] , minimum sampling size calculate 44 subject . We also assume 10 % drop-out rate , thus aim include 50 woman . As drop-out rate quickly rise higher expect , decide include 60 woman . In intention-to-treat analysis , value participant 6 month metformin placebo compare baseline value . Linear regression analysis change testosterone homeostasis model assessment ( HOMA ) index dependent variable perform examine potential relation change . The per protocol analysis include data participant complete study period , i.e . difference value participant placebo metformin , respectively , calculate , significance test perform difference .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>testosterone value upper normal limit oligo amenorrhea , periclimacteric gonadotrophin value , hyperprolactinaemia , diabetes mellitus , impaired thyroid , renal hepatic function , hormonal treatment , pregnancy , lactation wish fertility treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PCOS</keyword>
	<keyword>metformin</keyword>
	<keyword>obesity</keyword>
	<keyword>randomize control trial</keyword>
</DOC>